Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Change in Receivables (2019 - 2023)

Historic Change in Receivables for ADC Therapeutics (ADCT) over the last 5 years, with Q4 2023 value amounting to $4.0 million.

  • ADC Therapeutics' Change in Receivables fell 9064.71% to $4.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$47.8 million, marking a year-over-year decrease of 21177.93%. This contributed to the annual value of -$4.8 million for FY2024, which is 9001.65% up from last year.
  • Latest data reveals that ADC Therapeutics reported Change in Receivables of $4.0 million as of Q4 2023, which was down 9064.71% from -$2.7 million recorded in Q3 2023.
  • Over the past 5 years, ADC Therapeutics' Change in Receivables peaked at $42.7 million during Q4 2022, and registered a low of -$48.9 million during Q1 2023.
  • For the 5-year period, ADC Therapeutics' Change in Receivables averaged around -$361943.4, with its median value being -$1539.5 (2020).
  • In the last 5 years, ADC Therapeutics' Change in Receivables soared by 29856434.86% in 2022 and then plummeted by 141097709.17% in 2023.
  • Over the past 5 years, ADC Therapeutics' Change in Receivables (Quarter) stood at $150.0 in 2019, then plummeted by 766.67% to -$1000.0 in 2020, then crashed by 1332.2% to -$14322.0 in 2021, then soared by 298564.35% to $42.7 million in 2022, then tumbled by 90.65% to $4.0 million in 2023.
  • Its last three reported values are $4.0 million in Q4 2023, -$2.7 million for Q3 2023, and -$188000.0 during Q2 2023.